Revolutionizing Prostate Cancer
Treatment with Immunotherapy
Despite significant strides in oncology, developing a targeted immunotherapy for prostate cancer has remained elusive, primarily due to the difficulty in directing immune cells to the specific cancer cells in the prostate.
The Immunocine Cancer Center is changing that narrative. With a groundbreaking approach rooted in extensive research and clinical trials, we’re providing prostate cancer patients with with a new approach in their fight against cancer.
The Immunocine Cancer Center:
Harnessing Your Power to Heal
When it comes to cancer, time is everything. However, for many patients, potentially life-changing treatments remain within the confines of ongoing clinical trials.
Immunocine was founded to bridge this gap. Recognizing the urgent need for advanced treatment options, our sole purpose is to bring a revolutionary immunotherapy to those cancer patients unable to participate in the current clinical trials.
From our base in Cancun, Mexico, we offer our ground-breaking Dendritic Cell Immunotherapy, which is transforming outcomes for patients every day.
Real Results with Prostate Cancer
Chris M.
Stage 4 Prostate Cancer
In 2014, Chris was diagnosed with Stage 4 Prostate Cancer and immediately started Chemotherapy. By 2017, Chris was in need of a different treatment option. His cancer had spread to 30 different locations throughout his body. In addition, Chemotherapy had nearly killed him as well.
After reading the early research of Immunocine’s treatment, Chris traveled to Houston to meet with the research team. With two kids who were six and eight years old, Chris was willing to do whatever it took to beat his cancer.
After receiving an earlier version of Immunocine’s Dendritic Cell Treatment, Chris has seen his PSA level go from 212 to 0. His 30 tumors were destroyed, and Chris remains in remission to this day.
Our only priority is treating patients that will benefit from our treatment
Before considering our treatment as an option, please consider the inclusion criteria outlined to the left. In order to be eligible, you must meet these requirements.
Solid Tumors
Right now we only treat patients with solid tumors that can be biopsied by our medical staff.
Stable Immune System
For our treatment to be successful, a patient needs to have a functioning immune system.
Ability to Travel
Our treatment is administered exclusively at our facility in Cancún, Mexico.
Six-Week Treatment
Our treatment protocol requires three separate treatments, each two weeks apart.
Addressing the Challenges
Specific to Prostate Cancer
Localization Challenge
Due to their location within the prostate gland, traditional treatments can struggle to reach and effectively eliminate the cancer cells without causing collateral damage to healthy tissues.
Immunocine’s approach leverages the body’s own immune system, utilizing dendritic cells to precisely identify and attack cancer cells, sparing healthy cells in the process.
Reoccurence
Prostate cancer has a high rate of recurrence, posing a constant threat to patients even after successful initial treatments.
Immunocine’s dendritic cell immunotherapy not only targets existing cancer cells but also “trains” the immune system to recognize and attack any recurring cancer cells, offering the potential for long-term, durable responses.
Redefining Medical Tourism
for Cancer Patients
Clinical Validation
Immunocine’s Treatment is backed by over 15 years of research, 17+ publications, mutiple patents, and clinical successes.
Complete Medical Team
Our team of MDs, PhDs, RNs, and expert advisors provides patients with unusually comprehensive support.
cGMP Clean Room
We offer an exceptionally clean and comfortable space for your healing, complete with smiling and empathetic staff.
Frequently Asked Questions
Immunotherapy is a type of cancer treatment that helps a patient’s immune system fight cancer cells.
For prostate cancer, Immunocine’s approach uses sampled cells from the patient’s prostate and their dendritic cells to make a personalized treatment. This treatment will be administered near the prostate but can recognize and attack metastasized cancer cells throughout their body.
By enhancing the immune system’s ability to target cancer cells specifically, this treatment can spare healthy cells, leading to more precise and potentially less harmful therapy.
To be eligible for Immunocine’s Treatment, a prostate cancer patient needs to have the following:
-A tumor that can be biopsied either in the prostate or a metastasized location
-A functioning immune system so that the body is able to attack the cancer
-Ability to travel to Cancun, Mexico, to receive the treatment
If a patient is eligible for treatment, the Immunocine Medical Team will conduct a complimentary and comprehensive medical review of the patient’s medical records to ensure they are a good fit for our treatment. This takes 1 – 2 weeks, and once completed and approved, patients will work with our concierge team to start planning their trip and treatment.
For the Immunocine Treatment, prostate cancer patients will typically experience the effects of an immune response no different than when fighting a cold or the flu. This can include fatigue, fever, aches, swollen lymph nodes, and loss of appetite.
Additionally, patients may feel some soreness around their prostate. If the cancer has metastasized, patients may also feel a varying level of soreness at those locations, especially in sensitive areas.
Fortunately, these symptoms will reduce over time and typically only last a few weeks. Furthermore, these symptoms are only the result of the Immune System attacking the patient’s cancer and are a positive sign that the treatment is working.
To protect against autoimmunity, the prostate naturally is immunosuppressive, which makes it harder for untargeted immunotherapies to gain traction against a patient’s cancer. This is why the standard of care still opts to remove the entire prostate, and immunotherapies overall have provided marginally improved outcomes for prostate cancer.
However, unlike most immunotherapies, Immunocine’s Dendritic Cell Treatment provides a targeted immune response against cancer using a personalized treatment built with a patient’s cancer. This has led to exciting results for our prostate cancer patients, such as Chris M., featured earlier.
Apply today for a new approach to
your Prostate Cancer.
Once you submit your information form, we initiate a dedicated and personalized journey to provide you the most innovative prostate cancer treatments.
Step 1: Connecting with a Patient Coordinator
Upon receiving your submission, an Immunocine Patient Coordinator will contact you to schedule an introductory call.
This gives us an opportunity to get to know you, understand your needs better, and answer any preliminary questions you may have about our approach to prostate cancer.
Step 2: Complimentary Medical Evaluation
Following the introductory call, we’ll commence your complimentary medical evaluation.
Our goal during the medical evaluation is to determine if you will be a candidate for our treatment. We know waiting can be hard and we aim to complete this process in 3 – 5 business days.